Kimia Biosciences (BOM:530313) EBITDA Margin %: 0.00% (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530313 Kimia Biosciences Ltd BOM:530313
25 GF Score
Price ₹33.30
View Full Analysis

What is Kimia Biosciences EBITDA Margin %?

Kimia Biosciences BOM:530313 +0.15% 25 EBITDA Margin % is 0.00% as of . 20. GuruFocus rates BOM:530313 with a GF Score™ of 25/100. Among 961 Drug Manufacturers companies, Kimia Biosciences ranks worse than 104058.17% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Kimia Biosciences's EBITDA for the six months ended in . 20 was ₹0.00 Mil. Kimia Biosciences's Revenue for the six months ended in . 20 was ₹0.00 Mil. Therefore, Kimia Biosciences's EBITDA margin for the quarter that ended in . 20 was 0.00%.

Kimia Biosciences  (BOM:530313) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Kimia Biosciences EBITDA Margin % Related Terms

Kimia Biosciences EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Kimia Biosciences's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kimia Biosciences EBITDA Margin % Chart

Kimia Biosciences Annual Data
Trend
EBITDA Margin %

Kimia Biosciences Semi-Annual Data
EBITDA Margin %

BOM:530313 vs ZTS, UTHR: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kimia Biosciences EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's EBITDA Margin % falls into.


BOM:530313
25GF Score
Kimia Biosciences Ltd BOM:530313
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kimia Biosciences EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Kimia Biosciences's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

Kimia Biosciences's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Kimia Biosciences (BOM:530313) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Kimia Biosciences and its competitors. According to the industry distribution chart, Kimia Biosciences ranks #999999 out of 961 companies in the Drug Manufacturers industry.
Is Kimia Biosciences' EBITDA Margin % too high?
Kimia Biosciences' current EBITDA Margin % is 0.00%. Based on the distribution chart, Kimia Biosciences ranks #999999 out of 961 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Kimia Biosciences has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Kimia Biosciences' EBITDA Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kimia Biosciences ranks #999999 out of 961 companies for EBITDA Margin %. This places Kimia Biosciences in the lower half of its industry. The industry median EBITDA Margin % is 12.49. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.49, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Kimia Biosciences and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kimia Biosciences's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kimia Biosciences stock overvalued right now?
Kimia Biosciences (BOM:530313) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Kimia Biosciences' overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Kimia Biosciences (BOM:530313), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kimia Biosciences Business Description

Address Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Prucalopride, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.
25GF Score

Get the complete analysis for BOM:530313

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹33.30
Price